To ask the Secretary of State for Health and Social Care, what recent steps have been taken to reduce waiting times for ADHD assessments in the Constituency of Slough.

We recognise that, nationally, demand for attention deficit hyperactivity disorder (ADHD) assessments has grown significantly in recent years and that people are experiencing severe delays in accessing such services.

It is the responsibility of integrated care boards (ICBs) in England to make appropriate provision to meet the health and care needs of their local population, including providing access to ADHD assessment services. The Medium-Term Planning Framework, published 24 October 2025, was explicit that ICBs and providers are expected to optimise existing resources to reduce long waits for ADHD assessments and improve the quality of assessments by implementing existing and new guidance, as published.

The Thames Valley ICB and the Berkshire Healthcare NHS Foundation Trust have undertaken work to improve ADHD services in Slough and East Berkshire. This includes redesigning referral and triage pathways, increasing assessment capacity through additional commissioned providers, introducing digital support and self-management tools, and improving the information and support available to families. A wider transformation programme is also underway across Thames Valley to improve the consistency and quality of assessment pathways, provide support before, during, and after assessment, and strengthen collaboration between health, education, local authorities, and voluntary organisations. The programme aims to reduce waiting times, improve patient experience, and ensure people can access support based on need, rather than diagnosis alone.

The Government announced on 4 December 2025 the launch of an Independent Review into Prevalence and Support for Mental Health Conditions, ADHD and Autism. The final report, due in the summer, will inform our new approach, so people receive the right support, at the right time and in the right place. The review’s interim report, published at the end of March, sets out the evidence reviewed so far on prevalence, describes the impact of rising demand for diagnosis and support, identifies where the evidence is uncertain, and outlines the key questions for the next phase.